Free Trial
ETR:SBS

Stratec (SBS) Stock Price, News & Analysis

Stratec logo
€24.35 -1.10 (-4.32%)
As of 03/31/2025

About Stratec Stock (ETR:SBS)

Key Stats

Today's Range
€24.00
€24.90
50-Day Range
€24.35
€36.60
52-Week Range
€36.00
€49.65
Volume
22,314 shs
Average Volume
6,253 shs
Market Capitalization
$292.53 million
P/E Ratio
29.22
Dividend Yield
2.26%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Remove Ads
Receive SBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter.

SBS Stock News Headlines

EQS-News: STRATEC ANNOUNCES CHANGES TO 2025 FINANCIAL CALENDAR
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
Stratec Announces Changes to 2025 Financial Calendar
See More Headlines

SBS Stock Analysis - Frequently Asked Questions

Stratec's stock was trading at €29.80 at the start of the year. Since then, SBS stock has decreased by 18.3% and is now trading at €24.35.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stratec investors own include Great Portland Estates (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), China Hydroelectric Corp Foreign (CHC), Bio-Rad Laboratories (BIO) and Berkshire Hills Bancorp (BHLB).

Industry, Sector and Symbol

Stock Exchange
ETR
Sector
Medical
Industry
Medical Devices
Sub-Industry
Utilities
Current Symbol
ETR:SBS
CIK
N/A
Fax
N/A
Employees
1,464
Year Founded
N/A

Profitability

Trailing P/E Ratio
29.22
Forward P/E Ratio
6.77
P/E Growth
10.43
Net Income
$9.89 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$247.60 million
Cash Flow
€1.02 per share
Price / Cash Flow
23.85
Book Value
€18.74 per share
Price / Book
1.30

Miscellaneous

Free Float
N/A
Market Cap
$292.53 million
Optionable
Not Optionable
Beta
0.16
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (ETR:SBS) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners